18048822

Source:http://linkedlifedata.com/resource/pubmed/id/18048822

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013216, umls-concept:C0033522, umls-concept:C0034380, umls-concept:C0443252, umls-concept:C1522673
pubmed:issue	34
pubmed:dateCreated	2007-11-30
pubmed:abstractText	To evaluate and compare health-related quality of life (HRQOL) after conventional- and high-dose adjuvant chemotherapy in patients with high-risk breast cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8309333
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Epirubicin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Tamoxifen, http://linkedlifedata.com/resource/pubmed/chemical/Thiotepa
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1527-7755
pubmed:author	pubmed-author:AaronsonNeil KNK, pubmed-author:BuijsCiskaC, pubmed-author:HupperetsPierreP, pubmed-author:MouritsMarian J EMJ, pubmed-author:NooijMarianne AMA, pubmed-author:PostWendy JWJ, pubmed-author:RodenhuisSjoerdS, pubmed-author:SeynaeveCaroline MCM, pubmed-author:SmitWim J MWJ, pubmed-author:TenVergertEls MEM, pubmed-author:VoestEmileE, pubmed-author:WillemsePax H BPH, pubmed-author:de VriesElisabeth G EEG, pubmed-author:van HoeselQuirinus G C MQG, pubmed-author:van TinterenHarmH, pubmed-author:van der WallElskenE
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	25
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	5403-9
pubmed:meshHeading	pubmed-meshheading:18048822-Age Factors, pubmed-meshheading:18048822-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18048822-Breast Neoplasms, pubmed-meshheading:18048822-Carboplatin, pubmed-meshheading:18048822-Chemotherapy, Adjuvant, pubmed-meshheading:18048822-Cyclophosphamide, pubmed-meshheading:18048822-Dose-Response Relationship, Drug, pubmed-meshheading:18048822-Drug Administration Schedule, pubmed-meshheading:18048822-Epirubicin, pubmed-meshheading:18048822-Female, pubmed-meshheading:18048822-Fluorouracil, pubmed-meshheading:18048822-Humans, pubmed-meshheading:18048822-Longitudinal Studies, pubmed-meshheading:18048822-Menopause, pubmed-meshheading:18048822-Middle Aged, pubmed-meshheading:18048822-Neoplasm Staging, pubmed-meshheading:18048822-Peripheral Blood Stem Cell Transplantation, pubmed-meshheading:18048822-Prospective Studies, pubmed-meshheading:18048822-Quality of Life, pubmed-meshheading:18048822-Risk Factors, pubmed-meshheading:18048822-Tamoxifen, pubmed-meshheading:18048822-Thiotepa, pubmed-meshheading:18048822-Transplantation, Autologous
pubmed:year	2007
pubmed:articleTitle	Prospective study of long-term impact of adjuvant high-dose and conventional-dose chemotherapy on health-related quality of life.
pubmed:affiliation	University Medical Center Groningen and University of Groningen, Groningen, The Netherlands.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study